Actinium Pharmaceuticals, Inc. (Delaware)Actinium Pharmaceuticals, Inc. (Delaware)Actinium Pharmaceuticals, Inc. (Delaware)

Actinium Pharmaceuticals, Inc. (Delaware)

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪291.88 M‬USD
‪−48.82 M‬USD
‪81.00 K‬USD
‪28.69 M‬
Beta (1Y)

About Actinium Pharmaceuticals, Inc. (Delaware)

Sandesh Seth
New York
Employees (FY)
Actinium Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel targeted therapies. It also develops and markets medicines for relapsed or refractory cancer patients. The company was founded in 2000 and is headquartered in New York, NY.
Revenue to profit conversion
Debt level and coverage

See all ideas 

Summarizing what the indicators are suggesting.
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of ATNM is 9.69 USD — it has decreased by 1.12% in the past 24 hours. Watch Actinium Pharmaceuticals, Inc. (Delaware) stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on AMEX exchange Actinium Pharmaceuticals, Inc. (Delaware) stocks are traded under the ticker ATNM.
ATNM stock has risen by 7.91% compared to the previous week, the month change is a 45.93% rise, over the last year Actinium Pharmaceuticals, Inc. (Delaware) has showed a 15.36% increase.
We've gathered analysts' opinions on Actinium Pharmaceuticals, Inc. (Delaware) future price: according to them, ATNM price has a max estimate of 50.00 USD and a min estimate of 16.00 USD. Watch ATNM chart and read a more detailed Actinium Pharmaceuticals, Inc. (Delaware) stock forecast: see what analysts think of Actinium Pharmaceuticals, Inc. (Delaware) and suggest that you do with its stocks.
ATNM reached its all-time high on Apr 3, 2014 with the price of 450.00 USD, and its all-time low was 3.00 USD and was reached on Jun 1, 2012. View more price dynamics on ATNM chart.
See other stocks reaching their highest and lowest prices.
ATNM stock is 2.81% volatile and has beta coefficient of 1.16. Track Actinium Pharmaceuticals, Inc. (Delaware) stock price on the chart and check out the list of the most volatile stocks — is Actinium Pharmaceuticals, Inc. (Delaware) there?
Today Actinium Pharmaceuticals, Inc. (Delaware) has the market capitalization of ‪291.88 M‬, it has increased by 21.41% over the last week.
Yes, you can track Actinium Pharmaceuticals, Inc. (Delaware) financials in yearly and quarterly reports right on TradingView.
Actinium Pharmaceuticals, Inc. (Delaware) is going to release the next earnings report on Jul 29, 2024. Keep track of upcoming events with our Earnings Calendar.
ATNM net income for the last quarter is ‪−8.67 M‬ USD, while the quarter before that showed ‪−9.32 M‬ USD of net income which accounts for 7.01% change. Track more Actinium Pharmaceuticals, Inc. (Delaware) financial stats to get the full picture.
No, ATNM doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of May 20, 2024, the company has 49.00 employees. See our rating of the largest employees — is Actinium Pharmaceuticals, Inc. (Delaware) on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Actinium Pharmaceuticals, Inc. (Delaware) EBITDA is ‪−49.11 M‬ USD, and current EBITDA margin is ‪−63.12 K‬%. See more stats in Actinium Pharmaceuticals, Inc. (Delaware) financial statements.
Like other stocks, ATNM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Actinium Pharmaceuticals, Inc. (Delaware) stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Actinium Pharmaceuticals, Inc. (Delaware) technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Actinium Pharmaceuticals, Inc. (Delaware) stock shows the buy signal. See more of Actinium Pharmaceuticals, Inc. (Delaware) technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.